Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Revenue (2017 - 2019)

Historic Revenue for Iterum Therapeutics (ITRM) over the last 3 years, with Q1 2019 value amounting to $37000.0.

  • Iterum Therapeutics' Revenue fell 8062.83% to $37000.0 in Q1 2019 from the same period last year, while for Dec 2019 it was $37000.0, marking a year-over-year decrease of 9574.22%. This contributed to the annual value of -$3.3 million for FY2024, which is 511.11% down from last year.
  • As of Q1 2019, Iterum Therapeutics' Revenue stood at $37000.0, which was down 8062.83% from $239000.0 recorded in Q4 2018.
  • Over the past 5 years, Iterum Therapeutics' Revenue peaked at $349000.0 during Q4 2017, and registered a low of $37000.0 during Q1 2019.
  • Moreover, its 3-year median value for Revenue was $191000.0 (2018), whereas its average is $202000.0.
  • In the last 5 years, Iterum Therapeutics' Revenue skyrocketed by 5974.84% in 2018 and then tumbled by 8062.83% in 2019.
  • Over the past 3 years, Iterum Therapeutics' Revenue (Quarter) stood at $349000.0 in 2017, then plummeted by 31.52% to $239000.0 in 2018, then plummeted by 84.52% to $37000.0 in 2019.
  • Its last three reported values are $37000.0 in Q1 2019, $239000.0 for Q4 2018, and $254000.0 during Q3 2018.